Promoting tumor cell recognition by DCs can up-regulate the expression of chemokines, such as chemokine (C-X-C motif) ligand 1 protein (CXCL1) and chemokine (C-X-C motif) ligand 5 protein (CXCL5), and increase the infiltration and proliferation of immune cells at the site of tumor [71]. The gene discussed is CXCL1; the disease is neoplasm.